Rocket Propulsion Market value to hit $6 billion by 2027, Says Global Market Insights, Inc.
/
Date20 Dec 2019
Email Print Friendly Share Selbyville, Delaware, Dec. 19, 2019 (GLOBE NEWSWIRE) — Global Rocket Propulsion market revenue is projected to surpass USD 6 billion by... Read More →
Novo Reports Change of Directors
/
Date20 Dec 2019
Email Print Friendly Share VANCOUVER, British Columbia, Dec. 19, 2019 (GLOBE NEWSWIRE) — Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO; OTCQX: NSRPF) reports... Read More →
Purpose Investments Inc. Announces Revision to December 2019 Distributions for Purpose High Interest Savings ETF and Purpose US Cash ETF
/
Date20 Dec 2019
Email Print Friendly Share TORONTO, Dec. 19, 2019 (GLOBE NEWSWIRE) — Purpose Investments Inc. announced today a revision to the December 2019 distributions for Purpose... Read More →
Sonic Foundry Announces Fourth Quarter and Fiscal 2019 Financial Results
/
Date20 Dec 2019
Email Print Friendly Share MADISON, Wis., Dec. 19, 2019 (GLOBE NEWSWIRE) — Sonic Foundry, Inc. (OTC Pink Sheets: SOFO), the trusted leader for video creation... Read More →
Gladstone Commercial Announces Industrial Portfolio Acquisition
/
Date20 Dec 2019
Email Print Friendly Share MCLEAN, Va., Dec. 19, 2019 (GLOBE NEWSWIRE) — Gladstone Commercial Corporation (Nasdaq: GOOD) (“Gladstone Commercial”) announced today that it completed the... Read More →
Cabot Microelectronics Corporation to Release Financial Results for First Quarter of Fiscal 2020 After Market Close on February 5, 2020
/
Date20 Dec 2019
Email Print Friendly Share Aurora, IL, Dec. 19, 2019 (GLOBE NEWSWIRE) — Cabot Microelectronics Corporation (Nasdaq: CCMP), a leading global supplier of consumable materials to... Read More →
Annual Financial Report
/
Date20 Dec 2019
Email Print Friendly Share Hargreave Hale AIM VCT plc announced its results for the year ended 30 September 2019 on 19 December 2019. The full... Read More →
Axovant Provides Clinical Program Update for AXO-AAV-GM1, a Novel Investigational Gene Therapy for GM1 Gangliosidosis
/
Date20 Dec 2019
Email Print Friendly Share NEW YORK and BASEL, Switzerland, Dec. 19, 2019 (GLOBE NEWSWIRE) — Axovant Gene Therapies Ltd. (NASDAQ: AXGT) today announced preliminary findings... Read More →
Logica Ventures Corp. Completes Initial Public Offering
/
Date20 Dec 2019
Email Print Friendly Share TORONTO, Dec. 19, 2019 (GLOBE NEWSWIRE) — Logica Ventures Corp. (the “Corporation”) (TSXV: LOG.P) is pleased to announce that it has completed... Read More →